Cargando…

Targeting Antisense lncRNA PRKAG2-AS1, as a Therapeutic Target, Suppresses Malignant Behaviors of Hepatocellular Carcinoma Cells

Objective: Increasing evidence highlights antisense long non-coding RNAs (lncRNAs) as promising therapeutic targets for cancers. Herein, this study focused on the clinical implications and functions of a novel antisense lncRNA PRKAG2-AS1 in hepatocellular carcinoma (HCC). Methods: PRKAG2-AS1 express...

Descripción completa

Detalles Bibliográficos
Autores principales: Ou, Yanjiao, Deng, Yong, Wang, Hong, Zhang, Qingyi, Luo, Huan, Hu, Peng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8076551/
https://www.ncbi.nlm.nih.gov/pubmed/33928106
http://dx.doi.org/10.3389/fmed.2021.649279